Lataa...
Dendritic cell vaccines for high-grade gliomas
Glioblastoma (GBM) is the most common and fatal primary adult brain tumor. To date, various promising chemotherapeutic regimens have been trialed for use in GBM; however, temozolomide (TMZ) therapy remains the only US Food and Drug Administration-approved first-line chemotherapeutic option for newly...
Tallennettuna:
| Julkaisussa: | Ther Clin Risk Manag |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Dove Medical Press
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6067774/ https://ncbi.nlm.nih.gov/pubmed/30100728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S135865 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|